Phospho-BRCA1 (S1423) Antibody

What is the functional significance of BRCA1 phosphorylation at S1423?

Phosphorylation of BRCA1 at S1423 plays a crucial role in DNA damage response pathways. This phosphorylation event is mediated by ATM and ATR kinases following DNA damage and is specifically required for the G2/M cell cycle checkpoint control . Research has demonstrated that mutation of this serine residue to alanine (S1423A) abrogates the G2/M checkpoint but does not affect the ionizing radiation-induced S-phase checkpoint . The phosphorylation at S1423 is part of BRCA1's tumor suppressor function, maintaining genomic stability by ensuring cells do not enter mitosis prematurely when DNA damage is present . This precise regulation prevents the transmission of damaged DNA to daughter cells, thereby reducing cancer risk, particularly in breast and ovarian tissues.

How does phosphorylation at S1423 affect BRCA1's role in DNA repair mechanisms?

BRCA1 S1423 phosphorylation significantly influences DNA repair processes, particularly homologous recombination repair (HRR). Studies have shown that mutations in the SQ-cluster region of BRCA1, including S1423, can substantially reduce HRR efficiency . While a single S1423A mutation has modest effects on HRR, combined mutations including S1423 (such as the S1387A/S1423A double mutant) can reduce HRR to vector control levels . The experimental evidence indicates:

Importantly, these effects appear to be independent of PALB2 binding, as mutations in the SQ-cluster do not disrupt the BRCA1-PALB2 interaction . The phosphorylation ensures proper timing and completion of HRR before cells enter mitosis, preventing genomic instability.

What techniques can be used to detect BRCA1 phosphorylated at S1423?

Several validated techniques can be employed to detect BRCA1 phosphorylated at S1423:

• Western Blot (WB):

  • Recommended dilutions: 1:500-1:2000

  • Best performed with cell extracts treated with DNA damaging agents (ionizing radiation, anisomycin)

  • Phospho-specificity can be confirmed using lambda phosphatase treatment as negative control

  • Typical protein band appears at approximately 220 kDa

• Immunohistochemistry (IHC-P):

  • Recommended dilutions: 1:50-1:200

  • Epitope retrieval: Microwave heating at pH7 (95-98°C for 5 min, 100°C for 1 min)

  • Shows nuclear localization in tissues

• Immunocytochemistry/Immunofluorescence (ICC/IF):

  • Recommended concentration: 5-15 μg/ml

  • Successfully used to stain nuclei in cell lines like U2OS

  • Detection typically with fluorescent secondary antibodies (e.g., Alexa Fluor 488)

• ELISA:

  • Can be used for quantitative assessment of phosphorylation levels

For all applications, proper controls should include unphosphorylated samples (untreated cells) and phosphatase-treated samples to confirm antibody specificity.

How is BRCA1 S1423 phosphorylation regulated in the context of DNA damage?

BRCA1 S1423 phosphorylation is primarily regulated by ATM and ATR kinases, which are activated in response to DNA damage, particularly double-strand breaks . This regulatory process follows a specific cascade:

• DNA damage sensors detect lesions and activate ATM/ATR kinases

• These kinases recognize and phosphorylate the SQ-cluster region of BRCA1, which contains multiple SQ motifs including S1423

• The phosphorylation occurs rapidly after DNA damage (typically within 15-60 minutes)

• While ATM is the primary kinase responsible for this phosphorylation following ionizing radiation, ATR may compensate in ATM-deficient cells

Research has shown that IR-dependent phosphorylation at S1423 is evident in both wild-type and ATM-mutant cells, suggesting functional redundancy in this critical pathway . This phosphorylation works in concert with other modifications on BRCA1 to orchestrate the appropriate cellular response to DNA damage.

What is the relationship between BRCA1 S1423 phosphorylation and cancer development?

BRCA1 S1423 phosphorylation status has important implications for cancer development and progression. Research has revealed several key connections:

• Dysregulation of this phosphorylation event has been linked to increased cancer risk, particularly in breast and ovarian cancers

• Studies examining patient tissues have found correlations between pBRCA1 S1423 expression and estrogen receptor (ER) status in breast cancers :

  Parameter	EZH2 high pBRCA1 s1423−	EZH2 high pBRCA1 s1423+	EZH2 low pBRCA1 s1423−	EZH2 Low pBRCA1 s1423+	P value
  ER negative	29 (76.3%)	9 (75%)	9 (23.7%)	3 (25%)	<0.0001
  ER positive	16 (50%)	16 (50%)	27 (50%)	27 (50%)	NS

• Breast cancer cells with EZH2 knockdown show increased levels of pBRCA1 S1423 protein, suggesting a regulatory relationship

• The proper phosphorylation of S1423 ensures genomic stability by maintaining effective G2/M checkpoint control and enabling proper DNA repair

• Mutations that affect this phosphorylation site may contribute to tumorigenesis by allowing cells with damaged DNA to progress through the cell cycle, leading to genomic instability

How can researchers distinguish between the functional effects of different BRCA1 phosphorylation sites in the SQ-cluster?

To distinguish between the functional effects of different BRCA1 phosphorylation sites (such as S1387 vs S1423), researchers should employ a multi-faceted experimental approach:

• Site-specific mutant analysis:

  • Generate BRCA1 constructs with single mutations (S1387A, S1423A) and combined mutations (S1387A/S1423A)

  • Express these constructs in BRCA1-deficient cells (like HCC1937) to assess different cellular functions

  • Compare phenotypes to identify site-specific effects

• Checkpoint-specific assays:

  • For S1387 (S-phase checkpoint): Measure DNA synthesis after ionizing radiation using BrdU incorporation

  • For S1423 (G2/M checkpoint): Quantify mitotic entry after DNA damage using phospho-histone H3 staining

  • The data clearly shows that S1387 and S1423 regulate different cell cycle checkpoints, with S1387 controlling the S-phase checkpoint and S1423 controlling the G2/M checkpoint

• Homologous recombination analysis:

  • Use DR-GFP reporter assays in BRCA1-deficient cells reconstituted with different phospho-mutants

  • The experimental evidence demonstrates differential effects on HR efficiency:

    • S1387A: ~17% reduction

    • S1387A/S1423A: Significant reduction to background levels

    • S1387A/S1423A/S1457A/S1524A: Complete abrogation of HR

• Downstream pathway analysis:

  • Examine how different phosphorylation sites affect BRCA1's interaction with downstream effectors

  • Investigate pathway-specific outcomes using phospho-site-specific antibodies

This systematic approach reveals the distinct, non-redundant functions of different phosphorylation sites within the SQ-cluster of BRCA1.

What are the optimal experimental conditions for detecting transient phosphorylation at BRCA1 S1423 following DNA damage?

Detecting the transient phosphorylation of BRCA1 at S1423 following DNA damage requires carefully optimized experimental conditions:

• DNA damage induction:

  • Ionizing radiation: 10 Gy is typically effective, with peak phosphorylation occurring 30 minutes to 1 hour post-treatment

  • Chemical agents: Anisomycin or other DNA-damaging agents can be used as alternatives

• Sample preparation:

  • Harvest cells at multiple timepoints (15, 30, 60, 120 minutes post-damage)

  • Include phosphatase inhibitors in all buffers to preserve phosphorylation status

  • Perform rapid cell lysis at 4°C

• Western blot optimization:

  • Use freshly prepared samples

  • Load 50-100 μg protein per lane

  • For highly specific detection, use phospho-BRCA1 (S1423) antibody at 0.5-1 μg/mL

  • Include lambda phosphatase-treated samples as negative controls

  • Use SDS-PAGE gels with lower percentage acrylamide (6-8%) to better resolve the large BRCA1 protein

• Immunofluorescence conditions:

  • Fix cells with 4% paraformaldehyde

  • Use antibody at 5-15 μg/mL concentration

  • Detect with appropriate secondary antibodies (e.g., Alexa Fluor 488)

  • Nuclear counterstaining with DAPI helps confirm nuclear localization

These optimized conditions enhance detection sensitivity and allow for accurate temporal profiling of S1423 phosphorylation dynamics in response to DNA damage.

How do mutations in the SQ-cluster region affect the spatio-temporal dynamics of BRCA1 phosphorylation and DNA repair?

Mutations in the SQ-cluster region of BRCA1 significantly impact the spatio-temporal dynamics of phosphorylation and DNA repair processes:

• Temporal dynamics:

  • Wild-type BRCA1 shows prompt phosphorylation at S1423 following DNA damage, enabling timely cell cycle arrest and repair

  • SQ-cluster mutations (particularly combined mutations) lead to:

    • Prolonged and struggling homologous recombination repair late in the cell cycle

    • Altered timing of repair pathway choice

    • Failure to complete DNA repair before mitotic entry

• Spatial organization:

  • Phosphorylated BRCA1 normally localizes to sites of DNA damage and forms repair foci

  • Multiple SQ-cluster mutations can affect BRCA1's ability to properly accumulate at damage sites or form functional repair complexes

• Pathway switching:

  • BRCA1 with multiple phosphorylation site mutations (like 4P: S1387A/S1423A/S1457A/S1524A) shifts DNA double-strand break repair from homologous recombination to non-homologous end joining

  • This pathway switch is particularly problematic for complex DNA damage, resulting in:

    • Increased error-prone repair

    • Chromosomal aberrations

    • Mitotic catastrophe when cells enter division with unrepaired damage

• Mechanistic consequences:

  • While single phosphorylation site mutations show modest effects, combined mutations have synergistic negative impacts on repair dynamics

  • These mutations appear to affect repair timing rather than completely abolishing BRCA1's ability to participate in repair complexes

  • The temporal disruption results in cells entering G1 prematurely with unrepaired damage, leading to gross chromosomal aberrations

These findings highlight how proper phosphorylation of the SQ-cluster coordinates the timing and efficiency of DNA repair processes, particularly ensuring repair completion before mitotic entry.

How can phospho-BRCA1 (S1423) antibodies be used to evaluate the impact of BRCA1 variants of uncertain significance (VUS)?

Phospho-BRCA1 (S1423) antibodies provide valuable tools for assessing BRCA1 variants of uncertain significance (VUS) through several methodological approaches:

• Phosphorylation status assessment:

  • Express BRCA1 VUS in BRCA1-deficient cells (such as HCC1937)

  • Induce DNA damage (ionizing radiation or chemical agents)

  • Assess S1423 phosphorylation by Western blot using phospho-specific antibodies

  • Compare phosphorylation levels between wild-type BRCA1 and VUS

  • Identify variants that affect phosphorylation despite being distant from S1423

• Functional correlation studies:

  • Measure G2/M checkpoint activation in cells expressing VUS versus wild-type BRCA1

  • Assess homologous recombination efficiency using DR-GFP reporter assays

  • Evaluate cell survival after ionizing radiation

  • Examine chromosomal aberrations in metaphase spreads

  • Determine whether reduced phosphorylation correlates with functional defects

• Structural impact analysis:

  • For VUS that affect S1423 phosphorylation, investigate:

    • Whether they alter ATM/ATR kinase recognition motifs

    • If they cause conformational changes that mask the S1423 site

    • Their effects on protein-protein interactions that regulate phosphorylation

  • This is particularly relevant for variants like K898E that may disrupt regulatory interactions

• Immunohistochemical assessment:

  • Use phospho-BRCA1 (S1423) antibodies for IHC analysis of patient-derived samples

  • Compare phosphorylation patterns between normal and tumor tissues

  • Correlate with other biomarkers such as EZH2 expression and ER status

This comprehensive approach provides mechanistic insights into how VUS affect BRCA1 function through disruption of critical phosphorylation events, potentially aiding in their clinical classification.

What methodological approaches can resolve contradictory data regarding the role of S1423 phosphorylation in homologous recombination repair?

To resolve contradictory findings regarding S1423 phosphorylation's role in homologous recombination repair, researchers should implement the following methodological approaches:

• Standardized experimental systems:

  • Use isogenic cell lines (e.g., generate BRCA1-knockout cells and reconstitute with WT or S1423A mutant)

  • Employ CRISPR/Cas9 gene editing to create endogenous S1423A mutations, avoiding overexpression artifacts

  • Use multiple cell types to identify cell-specific effects

  • Consistent expression systems like adenoviral vectors can provide physiological expression levels

• Combinatorial mutation analysis:

  • Test single mutations (S1423A) alongside combined mutations (S1387A/S1423A, S1387A/S1423A/S1457A/S1524A)

  • Evidence shows that while single S1423A mutation has modest effects on HR, combined mutations have much stronger impacts

  • This approach can identify synergistic relationships between phosphorylation sites

• Mechanistic dissection:

  • Examine protein interactions of wild-type versus phospho-mutant BRCA1 proteins

  • The evidence shows that SQ-cluster mutations do not affect PALB2 binding , suggesting alternative mechanisms

  • Investigate downstream effectors of S1423 phosphorylation

• Temporal analysis of repair:

  • Monitor DNA repair dynamics throughout the cell cycle using time-course experiments

  • Research indicates that SQ-cluster mutations lead to prolonged repair attempts late in the cell cycle

  • Time-resolved studies can identify subtle defects in repair kinetics rather than complete repair failure

• Comprehensive phenotypic assessment:

  • Assess multiple endpoints beyond direct HR measurements:

    • Cell survival after DNA damage

    • Chromosomal aberrations

    • Mitotic catastrophe frequency

    • Repair pathway choice (HR vs. NHEJ)

  • This broader perspective may reconcile apparently contradictory findings by revealing context-specific effects

Through these rigorous methodological approaches, researchers can develop a more nuanced understanding of how S1423 phosphorylation contributes to homologous recombination repair, particularly in coordination with other phosphorylation events.